• Cognitive support
• Sports nutrition
Serving Size: 1 Capsule
Phosphatidylserine … 100 mg
Non-medicinal ingredients: microcrystalline cellulose, silicon dioxide. Capsule: hypromellose.
AOR Guarantees: that no ingredients not listed on the label have been added to the product.
Contains no wheat, gluten, corn, nuts, dairy, eggs, fish or shellfish.
What Is It?
Phosphatidylserine (PS) is a phospholipid that is a structural component of cell membranes but is most concentrated in the brain and cerebral cortex.
What Does It Do?
Primary Uses: PS plays an encompassing role in the functioning and structural integrity of nerve cell membranes. Studies have demonstrated that supplemental PS possesses the ability to reduce cognitive impairment. Clinical trials have also shown PS to be effective in other forms of cognitive dysfunction as well, including age-associated memory impairment.
Secondary Uses: There have also been several studies examining PS's ability to significantly reduce levels of the hormone cortisol, released by the body in response to stress. Research has focused on the connection between lower cortisol levels and elevated mood.
Who Should Take It?
Middle-aged and elderly people may benefit from phosphatidylserine's cognitive enhancing and protecting powers. It may also support athletes and those under stress by reducing the main stress hormone.
Take 1-3 capsules daily with/without food, or as directed by a qualified health practitioner.
Amaducc L, SMID Group. Phosphatidylserine in the treatment of Alzheimer's disease. Results of a multicenter study. Psychopharmacol Bull. 1988; 24:130-134.
Casamenti F, Scali C, Pepeu G. Phosphatidylserine reverses the age-development decrease in cortical acetylcholine release: a microdialysis study. Eur J Pharmac. 1991; 194:11-16.
Nunzi MG, Milan F, Guidolin D, Toffano G. Dendritic spine loss in hippocampus of aged rats. Effect of brain phosphatidylserine. Neurobiol Aging. 1987; 8:501-510.
Palmieri G, et al, 1987. “
Double-blind controlled trial of phosphatidylserine in subjects with senile mental deterioration.”
Clin. Trials J. 24: 73-83.
Sinforiani E, et al, 1987. “
Cognitive decline in aging brain: therapeutic approach with phosphatidylserine.”
Villardita C, et al, 1987. “
Multicentre clinical trial of brain phosphatidylserine in elderly; subjects with mental deterioration.”
Clin. Trials J. 24: 84-93.
Zannoti A, et al, 1987. “
Pharmacological properties of phosphatidylserine: effects on memory function.”
In, Nutrients and Brain Function, ed. Essman WB, pp. 95-102. New York: Karger.
Disclaimer: This content is subject to change. The information is intended to inform and educate; it does not replace the medical evaluation, advice, diagnosis or treatment by a healthcare professional. www.nhpassist.com © 2014 NDAssist Inc. and/or its affiliates. All rights reserved.